Factors influencing adherence to antiretroviral therapy among HIV/AIDS patients in the Ga West Municipality. Ghana IJID regions. 2022;1(3):218–25. Article Google Scholar Abubakari A, Issah H, Mutaka MA, Asumah MN. Determinants of virological failure in HIV patients on highly active ...
Data from the 2022 Ghana Demographic and Health Survey [GDHS] showed that 54% of women and 24% of men aged 15–49 years had ever tested for HIV and received their results. Out of this, the uptake of HTC among those aged 15–24 was 27.8% for females and 8.3% for males [8]. Also...
Nine (6.8%) women reported being HIV positive, while the remaining were either HIV negative or did not know their status. About a third (27.5%) had undergone prior precancer screening. Women screened in the outreach setting were significantly younger than those screened in the clinic (p-value...
High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting. Infect Agent Cancer. 2023;18(1):1–13. Article Google Scholar Ebu NI, Mupepi SC, Siakwa MP, Sampselle CM. Knowledge, practice, and ...
Strictly following antiretroviral therapy (ART) is essential in managing HIV and AIDS and attaining viral suppression. However, adherence to ART remains a complex challenge among persons living with HIV (PLHIV) and it is influenced by various individual
Key populations (KPs) such as female sex workers (FSWs), men who have sex with men (MSM), people who inject drugs (PWID), and their partners contribute more than a quarter (27.5%) of new HIV infection in Ghana. Oral pre-exposure prophylaxis (PrEP) can su
Abstract Purpose Roughly 40 million children experience adversities every year and this has potential to impact the wellbeing of children. Short and long-term consequences include sexual abuse and exploitation, self-harm, excessive use of alcohol and harmful drugs. This paper discusses the association...
Advances in health and technology have reduced HIV to a more manageable communicable disease. Yet, stigma and discrimination against people with HIV remain critical barriers to ending the pandemic by 2030. Due to limited literature on stigma and discrimi